thumbnail image
  • About REACTA 2024
  • Agenda & Speakers
  • Partners
  • Sponsor
  • Abstracts
  • Venue/Travel Information
  • …  
    • About REACTA 2024
    • Agenda & Speakers
    • Partners
    • Sponsor
    • Abstracts
    • Venue/Travel Information
broken image
broken image
broken image
  • About REACTA 2024
  • Agenda & Speakers
  • Partners
  • Sponsor
  • Abstracts
  • Venue/Travel Information
  • …  
    • About REACTA 2024
    • Agenda & Speakers
    • Partners
    • Sponsor
    • Abstracts
    • Venue/Travel Information
Registration
  • About REACTA 2024
  • Agenda & Speakers
  • Partners
  • Sponsor
  • Abstracts
  • Venue/Travel Information
  • …  
    • About REACTA 2024
    • Agenda & Speakers
    • Partners
    • Sponsor
    • Abstracts
    • Venue/Travel Information
broken image
broken image
broken image
  • About REACTA 2024
  • Agenda & Speakers
  • Partners
  • Sponsor
  • Abstracts
  • Venue/Travel Information
  • …  
    • About REACTA 2024
    • Agenda & Speakers
    • Partners
    • Sponsor
    • Abstracts
    • Venue/Travel Information
Registration
broken image
  • Welcome to REACTA 2024

    Register now to receive CFD credits for health professionals.

    If you are...

    Clinical trial investigators, study coordinators,

    clinical study project management professionals,

    researchers, and students!

     

    Register Now!
    broken image
  • broken image

    Why Join REACTA 2024

    Professional growth, business development, and social networking!
  • REACTA 2024 Conference Proceedings (click to download)

    REACTA 2024 Forum

    August 02, 2024 (Friday)

    From Ideation to Validation: Clinical Trials in the Digital Era

    Welcome and Opening Ceremony

    broken image

    Ray-Jade Chen

    Chairman

    Board of Trustees

    Taipei Medical University

    broken image

    Lih-Jiuan Hsu

    Deputy Executive Director

    Center for Drug Evaluation

    Session 1: Clinical trials in new era: trends and emerging technologies   

    Part I: Streamlined Clinical Trials

    Keynote- Streamlined clinical trials: trends and key success

    1. Streamlined trials: an introduction and TMU involvement

    2. Streamlined academic renal trials: an EMPA-KIDNEY case study

    broken image

    Moderator

    Wen-Chang Chang

    Academician of Academia Sinica &

    Chair Professor, Graduate Institute of Medical Sciences,

    Taipei Medical University

    broken image

    Moderator

    Akhmal Yusof

    Chief Executive Officer,

    Clinical Research Malaysia

    broken image

    Mai-Szu Wu

    President, Taipei Medical University

     

    Wu, a TMU School of Medicine graduate, has held various leadership rolesat TMU and is currently President of the Taiwan Society of Nephrology and Chairman of the Taiwan Kidney Foundation. Trained at INSERM, he established a nephrology lab, led significant clinical trials, and initiated a translational lab at TMUH. Wu aims to elevate TMU to a premier international medical university by focusing on value-based healthcare, digital transformation, and sustainable development.

    Slides Download
    broken image

    Lai Seong Hooi

    Consultant Nephrologist & Editor,

    Malaysian Dialysis and Transplant Registry

    She was President of the Malaysian Society of Nephrology from 2004 -2006 and coordinated numerous multinational trials in Malaysia, including SHARP and EMPA-KIDNEY. She participated in several local studies, including three CAPD RCTs and two cost-effectiveness studies on dialysis. With over 70 publications, she has been on the editorial board of Transplantation Proceedings since 2023 and the editor of the Malaysian Dialysis and Transplant Registry since 2022.

    Slides Download

    Part II: Data Technology and Clinical Validation

    Topic 1: The New Era of AI in Clinical Research (pre-recorded)
    Topic 2: Supporting and Validating Clinical Trials through Global RWD/RWE Collaboration with OHDSI

    broken image

    Moderator

    Min-Huei Hsu

    Chief Data Officer, Office of Data Science, Taipei Medical University

    broken image

    Moderator

    Zu-Hao Chang

    Director, Graduate Institute of Biomedical Informatics, Taipei Medical University

    broken image

    Yu Chuan Jack Li

    Distinguished Professor, Graduate Institute of Medical Informatics, Taipei Medical University

    Li, a top AI in medicine and translational biomedical informatics expert, is ranked among the top 2% of scientists globally. He has led numerous national AI projects in disease prevention and patient safety and developed the largest temporal phenomic stochastic model based on medical data. Li's achievements have earned him fellowships in prestigious health informatics colleges and numerous awards.

    broken image

    Jason C. Hsu

    Associate Professor, International Ph.D. Program

    in Biotech and Healthcare

    Jason C. Hsu, PhD, is an expert in real-world data and evidence in medicine, and an Associate Professor at Taipei Medical University. He holds key leadership positions in data science and clinical research centers and is the Taiwan Chapter Leader of OHDSI. Trained at Harvard Medical School, Dr. Hsu leads large-scale RWD/RWE projects to advance digital and precision medicine globally.

    Slides Download

    Part III: Trends and New Technology in Cell Therapy

    Topic 1: Clinical Trial of Adaptive Cell Therapy
    Topic 2: Next-generation Cell-based Immunotherapy via Antibody Cell Conjugation

    broken image

    Moderator

    Long-Sheng Lu

    Associate Director, Center of Cancer Translational Medicine, Taipei Medical University

    broken image

    Moderator

    Yi-Fang Chang

    Vice Superintendent, Taitung MacKay Memorial Hospital

    broken image

    Sung Yong Oh

    Professor, Department of Internal Medicine,

    Dong-A University Hospital

    Oh, a distinguished clinician in hematology and oncology, has been aProfessor at Dong-A University Medical Center since March 2020. He earned his PhD and Master's degrees from Dong-A University and has been the Director of Dong-A University Hospital Clinical Trial Center since August 2019. Since March 2022, he has also served as Principal of the Busan, Ulsan, and Gyeongnam Regional Society of Medical Oncology, significantly contributing to research and patient care.

    broken image

    Sonny Hsiao

    CEO/CSO, President and Co-Founder of Acepodia

     

    Dr. Sonny Hsiao, CEO, President, and Co-Founder of Acepodia, was awardedthe Dr. Y-T Lee Prize for his achievements in Chemistry. He has extensive experience in immune cell therapy development, leading to the creation of
    Acepodia’s novel ACC platform, based on Nobel Laureate Professor Carolyn Bertozzi's work in biorthogonal chemistry. Dr. Hsiao worked on this pioneering research while earning his Ph.D. at UC Berkeley. He holds a B.S. in Chemistry
    from National Taiwan University and a Ph.D. in Chemistry and Molecular Cell Biology from UC Berkeley.

    Part IV: Future of Decentralised Clinical Trials

    Topic 1: Embracing the Future: Preparing Sites for Decentralized Clinical Trials (DCT) Innovation 

    Topic 2: Activities to Promote DCTs in Japan

    Topic 3: Local Care Model – Patient Centric Approach in Malaysia

    Topic 4: Practical Implementation of Decentralized Clinical Trials inJapan and Prospects in Asia

    broken image

    Moderator

    Teh-Ying Chou

    Professor, Graduate Institute of Clinical Medicine

    broken image

    Moderator

    Chien-Tai Hong

    Director, Department of Medical Research, Taipei Medical University Shuang Ho Hospital

    broken image

    Mandy Yang

    Associate Director, Clinical Operations, Clobal Clinical Operations, Syneos Health

    Mandy Yang currently serves as Country Head of Clinical Operations at Syneos Health. Leading the Taiwan team in global trials across various therapeutic areas, Mandy's diverse experience stems from collaborations with different sponsors and studies. Her prior experience in hospital settings enriches her understanding of clinical practice and patient care, fueling her commitment to keeping Taiwan at the forefront of clinical trial innovations, including decentralized clinical trials (DCTs).

    broken image

    Mariko Kawakami

    Pharmacist, ARO HQ Office,

    Chiba University Hospital Clinical Research Center

    Ms. Mariko Kawakami has graduated from Tokyo University of Pharmacy andLife Sciences. She joined the Chiba University Hospital Clinical Research Center in 2021. She was first in charge of working with the Institutional Review Board and was mainly involved in the review of research involving genome analysis. From 2023, she started her career as a study manager for investigator-initiated registry trial.

    broken image

    Nor Hafiza Johari

    Clinical Operations Manager,

    Clinical Research Malaysia

     

    Nor Hafiza Johari graduated from the Universityof Putra Malaysia with aBachelor of Science in Biology. Currently, she is the Clinical Operations Manager at Clinical Research Malaysia. For the past 12 years, she has engaged with different sponsors, CROs, investigators, and trial sites to assist in the conduct of trials. She leads her team to ensure smooth operations, compliance
    with regulations, and achievement of company objectives.

    broken image

    Shinsuke Muto

    President, DCT Japan Co. and Tetsuyu Institute Healthcare Corporation
    Chairman, IntegrityHealthcare Co., Ltd.

    Dr. Muto, a former cardiologist for the Emperor and Empress of Japan. Hebecame Chairman of Integrity Healthcare in 2016, founded DCT Japan in 2022, and is a clinical professor at Tokyo Medical and Dental University. He also advises the Ministry of Health, Labour and Welfare and is a member of the Regulatory Reform Committee of the Japan Association of Corporate Executives.

    Part V: Sharing from Clinical Research Centers in Taiwan

    broken image

    Moderator

    Shian-Ying Sung

    Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University

    broken image

    Moderator

    Hideki Hanaoka

    Head of Clinical Research Center, Chiba University Hospital

    broken image
    broken image

    Chun-Jen Liu

    Director of the Hepatitis Research Center and Clinical Trial Center, National Taiwan University Hospital

    Chun-Jen Huang

    Dean, Officeof Human Research, Taipei Medical University

    Slides Download

    Session 2: International Collaborative Trials: Opportunities and Challenges   

    Topic 1: Communication tips from past experience inestablishing new international collaboration for clinical trials (pre-recorded)

    Topic 2: Enhancing Innovativeand Investigator-Initiated Clinical Trials in Malaysia

    Topic 3: Rethinking Clinical Trials: Patient Reported Outcome Measures

    broken image

    Moderator

    Jiunn-Horng Kang

    Dean, College of Biomedical Engineering, Taipei Medical University

    broken image

    Moderator

    Jer-Hwa Chang

    Director, Clinical Research Center, Taipei Municipal Wanfang Hospital

    broken image

    Lee Farrand

    CEO, Yuhan Australia& New Zealand

     

    Dr Farrand manages operations in Australia and New Zealand for SouthKorea's largest pharmaceutical company, Yuhan Corporation. He also supports licensing activities for a rapidly growing Korean bio-venture called GI Innovation.

    broken image

    Sheamini Sivasampu

    Director, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia

    Dr. Sheamini Sivasampu is a Public Health Physician and the Director ofthe Institute for Clinical Research (ICR) at the Ministry of Health (MOH) in Malaysia. She oversees clinical trials, epidemiology, and digital health research across a network of 37 clinical research centres. Additionally, she has
    extensive experience in evidence-based policymaking and has served as a visiting scientist at Harvard, currently presiding over the Association of Clinical Research Malaysia.

    broken image

    Angela Wang

    Clinical Professor, Duke-NUS Medical School

     

    Professor Angela Wang is currently a Clinical Professor at theSingHealth Duke-NUS Academic Medical Centre and Senior Consultant at Singapore General Hospital. She has an international reputation for her research in cardiovascular-kidney-metabolic health, chronic kidney disease, and biomarkers for personalized care. Her latest work focuses on clinical trials and innovations in kidney disease outcomes, including precision and preventive
    medicine, and she leads several major clinical trials.

    Topic 1: Phase 4 Clinical Trial for Cyclosporine A for Kawasaki Disease(pre-recorded)

    Topic 2: Evolving Global Clinical Trials Sites landscape
    Topic 3: Collaborative Networks for Clinical Cardiovascular Trials

    broken image

    Moderator

    Chih-Hwa Chen

    Vice Superintendent, Taipei Medical University Shuang Ho Hospital

    broken image

    Moderator

    Jaw-Wen Chen

    Professor, Division of Cardiology

    broken image

    Hiromichi Hamada

    Professor, Department of Pediatrics,

    Graduate School of Medicine, Chiba University, Japan

    Graduating with an MD from Chiba University School of Medicine in 1990,Dr. Hamada Hiromichi completed postgraduate training at Chiba University Hospital by 1997. He earned a PhD from Chiba Graduate School of Medicine in 2000 and held postdoctoral fellowships in cell and vascular biology. He served as a staff physician and faculty member at Tokyo Women’s Medical University from 2007 to 2019. Since 2021, he has been a Professor of Pediatrics at Chiba University's Graduate School of Medicine.

    broken image

    Luis Segovia Sordo

    Director, Site Alliances APAC & Hong Kong Office

     

    Luis has over 25 years of experience in clinical trials, having workedin Europe, US, and Asia. He excels in building and managing clinical trial teams, focusing on site relationships and business development. Passionate about fostering growth through site-industry relationships, he has a talent for working across cultures and continents. Recently, he is very excited about the increased use of Real World Data andAI in Health Care and Clinical Research.

    Slides Download
    broken image

    Derek John Hausenloy

    Professor and Research Director, National Heart Centre Singapore

    Derek Hausenloy is a Professor in the Cardiovascular & Metabolic Disorders Signature Program at Duke-NUS Medical School and Director of the National Heart Research Institute Singapore. He conducts research in ischaemic
    heart disease, heart failure, cardio protection, and cardiac MRI, focusing on novel therapies to protect the heart against acute ischaemia/reperfusion injury and heart failure. His work spans from cellular and animal models to large
    clinical trials, and he uses human iPSC-derived cardiomyocytes to study cardiomyopathies and discover new treatment targets.

    Slides Download

    Session 3: Experience Sharing of Key Clinical Studies in Taiwan

    Topic 1: Precision diagnosis, Translational Research, and Multicenter IIT Phase II Trial of Atypical Teratoid Rhabdoid Tumors in Children: Experience in Taiwan

    Topic 2: Clinical Trials for Neurological Diseases in Taipei Medical University, Taiwan

    Topic 3: Xpert MTB/RIF Assayas the Initial Diagnostic Test for Pulmonary Tuberculosis in Taiwan: a Prospective, Multi-center, Randomized, Pragmatic Trial

    Topic 4: Clinical Trials for Cardiovascular Diseases in Taipei Medical University, Taiwan

    broken image

    Moderator

    Shian-Ying Sung

    Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University

    broken image

    Moderator

    Chun-Che Shih

    Executive Vice President, Taipei Medical University

    broken image

    Tai-Tong Wong

    Professor, Graduate Institute of Clinical Medicine, Taipei Medical University

    Dr. Wong is a renowned specialist in pediatric neurosurgery,focusing on pediatric brain and spinal tumors, epilepsy surgery in children, and hydrocephalus. Currently serving as Chairman of the Division of Pediatric Neurosurgery at TMUH and Director of the Pediatric Brain Tumor Program, Dr. Wong has extensive experience in neurosurgical care. He has held significant leadership positions, including President of the International Society of Pediatric Neurosurgery and the Taiwan Society for Pediatric Neurosurgery.

    broken image

    Chaur-Jong Hu

    Dean, Medical College,

    Taipei Medical University

    Dr. Chaur-Jong Hu, founding director of the Dementia Center at TaipeiMedical University-Shuang Ho Hospital, is the Dean of the College of Medicine at Taipei Medical University. With extensive experience in clinical trials for neurological diseases, has published over 250 peer-reviewed papers and serves as Executive Supervisor of the Taiwan Neurological Society and is a Fellow of the American Heart Association.

    Slides Download
    broken image

    Chen-Yuan Chiang

    Vice Superintendent,

    Taipei Municipal Wanfang Hospital

    Dr Chiang is a clinician trained in Taiwan, specialized in respiratoryand critical care medicine, obtained the degree of MPH at UC- Berkeley, US and Dr Philos at University of Bergen, Norway. He joined The International Union Against Tuberculosis and LungDisease (The Union), Paris, France in 2003 and was Director, Department of Lung Health, The Union, between 2007-2015. Currently, he is a Vice Superintendent of WanFang Hospital, and Professor of Medicine at Taipei Medical University.

    Slides Download
    broken image

    Ju-Chi Liu

    Vice Superintendent, Taipei Medical University Shuang Ho Hospital

    Dr. Ju-Chi Liu is a Professor in the Division of Cardiology, Departmentof Internal Medicine at the School of Medicine. His research interests include atherosclerosis, hypertension, and molecular biology in the cardiovascular system. Dr. Liu currently serves as the Deputy Director of the School of Medicine and Superintendent of Taipei Medical University Shuang Ho Hospital.

    Session 4: Industrial Leaders' Panel Discussion   

    broken image

    Moderator

    Chin-Wei Wang

    Director, Division of Periodontics, Department of Dentistry, Taipei Medical University Hospital

    broken image

    Moderator

    Tina Sun

    President, Taiwan Clinical Research Association (TCRA)

    broken image
    broken image

    Carol Chen

    Oncology Country Head

    Site Management & Monitoring (SMM) Taiwan
    AstraZeneca Taiwan Limited

    broken image

    Anchi Huang

    Head of Site Management

    Medical Department
    Bayer Taiwan Co., Ltd.

    broken image

    Keris Huang

    Executive Director

    Global Clinical Trial Operations
    MSD Taiwan

    broken image

    Shuling Cheng

    President
    Oneness Biotech 

    broken image

    Tien Li Chen

    Associate Director

    Site and Patient Solution
    Syneos Health

    Closing Remarks

    broken image

    Chun-Jen Huang

    Chairperson, REACTA 2024

    Dean

    Officeof Human Research

    Taipei Medical University

  • REACTA2024 Forum

    August03, 2024 (Saturday)

    From Ideation to Validation: Clinical Trials in the Digital Era

    Welcome and Opening Ceremony

    broken image

    Chun-Che Shih

    Executive Vice President

    Taipei Medical University

    Session 5: Country Updates from the Region

    Topic 1: CCRC Activities and Clinical Trial Networks as AROs in Japan

    Topic 2: Reflections on Clinical Trials in the Era of Evidence-based Medicine

    Topic 3: Challenges and Opportunity of Cancer Clinical Trials in Taiwan

    Topic 4: Opportunities in Conducting Multi-Regional Clinical Trials in Malaysia

    broken image

    Moderator

    Kang-Yun Lee

    Executive Vice President,

    Taipei Medical University

    broken image

    Moderator

    Sung Yong Oh

    Professor,

    Department of Internal Medicine,

    Dong-A University Hospital

    broken image

    Hideki Hanaoka

    Head of Clinical Research Center,

    Chiba University Hospital

    Dr. Hanaoka graduated from Chiba University Medical School and joinedPMDA as a medical reviewer in 2000. He was chief reviewer at NDA 5th review division of PMDIC. In 2003, he moved to Chiba University Hospital Clinical Research Center. He has been director of CCRC since 2008 and professor of the hospital since 2010. In 2023, he became deputy director of Chiba University Hospital. Chiba University Hospital has been one of the core clinical research hospitals since 2012.

    broken image

    Edwin Chan

    Chief Scientific Officer,

    Singapore Clinical Research Institute

    Edwin Chan is a clinical epidemiologist with extensive expertise in clinical research and evidence synthesis. He teaches research literature critical appraisal skills to medical students (Duke -NUS Medical School) and mentors students in clinical research (MCI programme, NUS). He has taught many research methodology courses on clinical trials, biostatistics, epidemiology, clinical practice guidelines (CPG) development, meta-analysis & evidence-based medicine (EBM). His interests are in the teaching of critical appraisal skills, epidemiology, health technology assessment and evidence synthesis.

    Slides Download
    broken image

    Chao-Hua Chiu

    Vice Superintendent,Taipei Cancer Center, Taipei Medical University

    Dr. Chao-Hua Chiu is a Professor at the School of Medicine and the Vice Superintendent at Taipei Cancer Center, Taipei Medical University. He specializes in Pulmonology and Medical Oncology, with clinical and research interests in low-dose CT lung cancer screening and the management and new drug development for lung cancer, mesothelioma, and thymic malignancies. Dr. Chiu trained at Taipei Veterans General Hospital and was a visiting scientist at MD Anderson Cancer Center.

    Slides Download
    broken image

    Akhmal Yusof

    Chief Executive Officer,

    Clinical Research Malaysia

    Dr. Yusof graduated from the Royal College of Surgeons in Ireland in1992 and practiced medicine for 10 years. He then gained extensive experience in the pharmaceutical industry, leading the Medical Department at AstraZeneca Malaysia, Singapore & Brunei for 13 years. Since 2015, he has been the
    Chief Executive Officer of Clinical Research Malaysia (CRM) and serves on the National Committee for Clinical Research and the Board of Trustees of the National Institute of Biotechnology Malaysia.

    Slides DownloadSession 6: Research Innovation and Clinical Validation

    Topic 1: Allogeneic platelet lysates for brain administration and treatment of neurological disorders

    Topic 2: Translational research experience sharing using TMU biobank

    Topic 3: Novel HDAC6 Inhibitor G211: Preclinical Study and Potential in Human Cancer Treatment

    Topic 4: Electrospun nanofiber artificial bone substitutes

    broken image

    Moderator

    Pei-ShanTsai

    Dean, College of Nursing, Taipei Medical University

    broken image

    Moderator

    Yi-Hua Chen

    Dean,College of Public Health, Taipei Medical University

    broken image

    Thierry Pierre Robert Burnouf

    Vice Dean, College of Biomedical Engineering, Taipei Medical University

    Slides Download
    broken image

    Wei-Chung Yang

    Jointly Appointed Professor,

    Master Program in Clinical Genomics and Proteomics,

    Taipei Medical University

    broken image

    Wei-Chun HuangFu

    Vice Dean, College of Medical Science and Technology, Taipei Medical University

    broken image

    Yi-Jie Kuo

    Director, Department of Orthopaedics, Taipei Municipal Wanfang Hospital

    Slides Download

    Session 7: Updates on the Latest Regulations and Practices on Clinical Trials
    (In Chinese)

     

    Topic 1: Decentralized Clinical Trial, DCT

    Topic 2: The Challenges and Future Developments of Regenerative Medicine in Taiwan

    broken image

    Moderator

    Chih-Shung Wong 

    Director, Anesthesiology Department, Cathay General Hospital

    broken image

    Moderator

    Chih-Han Lin

    Director, JIRB Administration Section, Taipei Medical University

    broken image

    Yi-Ling Lu

    Section Chief, Division of Regulatory Affairs and Compliance

    broken image

    Liu Yueh-ping

    Director-General, Department of Medical Affairs, Ministry of Health and Welfare

    Session 8: Student Research Awards Oral Presentation 

    Topic 1: OncoPharmGuard: Enhancing Cancer Treatment throughAI-Driven Pharmacogenomics

    Topic 2: EpCAM-targetedcombinatorial therapeutics attenuates cancer stemness: A platformfor colorectalcancer treatment

    Topic 3: Elevated serum GDF15 level as an early indicator forproximal tubular cell injury in acute kidney injury

    Topic 4: The Anti-inflammation Effects of Exosomal Delivery ofhsa-let-7i-5p and the Underlying Mechanism

    Closing Remarks

    broken image

    Chun-Jen Huang

    Chairperson, REACTA 2024

    Dean

    Officeof Human Research

    Taipei Medical University

2024 REACTA TW

    Home
    Register
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More